SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-474751
Filing Date
2013-12-16
Accepted
2013-12-16 17:20:28
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d608283d10qa.htm 10-Q/A 253420
2 EX-31.1 d608283dex311.htm EX-31.1 3042
3 EX-31.2 d608283dex312.htm EX-31.2 3026
4 EX-32.1 d608283dex321.htm EX-32.1 4481
  Complete submission text file 0001193125-13-474751.txt   4384088

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ck0001042074-20130930.xml EX-101.INS 527735
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001042074-20130930.xsd EX-101.SCH 46483
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001042074-20130930_cal.xml EX-101.CAL 58634
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001042074-20130930_def.xml EX-101.DEF 293944
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001042074-20130930_lab.xml EX-101.LAB 380713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001042074-20130930_pre.xml EX-101.PRE 343588
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55021 | Film No.: 131279783
SIC: 2834 Pharmaceutical Preparations